These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 13823727)

  • 21. Survival of Streptococcus pyogenes within host phagocytic cells: a pathogenic mechanism for persistence and systemic invasion.
    Medina E; Goldmann O; Toppel AW; Chhatwal GS
    J Infect Dis; 2003 Feb; 187(4):597-603. PubMed ID: 12599076
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Survival of group A streptococci in dried human blood.
    Reitmeyer JC; Ewert A; Crawford MA; Reitmeyer GR; Mock L
    J Med Microbiol; 1993 Jan; 38(1):61-3. PubMed ID: 8418296
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Virulence of group A streptococci for mice in relation to the production and destruction of hyaluronic acid.
    PIKE RM
    J Infect Dis; 1948; 83(1):19-22. PubMed ID: 18869803
    [No Abstract]   [Full Text] [Related]  

  • 24. Unimpaired function of human phagocytes in the presence of phagocytosis-resistant group A streptococci.
    Manjula BN; Schmidt ML; Fischetti VA
    Infect Immun; 1985 Dec; 50(3):610-3. PubMed ID: 3905607
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Accessory plasma factors involved in the bactericidal test for type-specific antibody to group A Streptococci. II. Human plasma cofactor (s) enhancing opsonization of encapsulated organisms.
    STOLLERMAN GH; RYTEL M; ORTIZ J
    J Exp Med; 1963 Jan; 117(1):1-17. PubMed ID: 13984363
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hyaluronic acid capsule is a virulence factor for mucoid group A streptococci.
    Wessels MR; Moses AE; Goldberg JB; DiCesare TJ
    Proc Natl Acad Sci U S A; 1991 Oct; 88(19):8317-21. PubMed ID: 1656437
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The leukotoxic action of streptococci.
    WILSON AT
    J Exp Med; 1957 May; 105(5):463-84. PubMed ID: 13428916
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Virulence of Group A Streptococci Is Enhanced by Human Complement Inhibitors.
    Ermert D; Shaughnessy J; Joeris T; Kaplan J; Pang CJ; Kurt-Jones EA; Rice PA; Ram S; Blom AM
    PLoS Pathog; 2015 Jul; 11(7):e1005043. PubMed ID: 26200783
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of M protein in phagocytosis. II. Opsonization of Streptococcus pyogenes in vitro.
    Tylewska S; Hryniewicz W
    Zentralbl Bakteriol Orig A; 1979 Oct; 245(1-2):44-7. PubMed ID: 44622
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Incremental Contributions of FbaA and Other Impetigo-Associated Surface Proteins to Fitness and Virulence of a Classical Group A Streptococcal Skin Strain.
    Rouchon CN; Ly AT; Noto JP; Luo F; Lizano S; Bessen DE
    Infect Immun; 2017 Nov; 85(11):. PubMed ID: 28808160
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of M protein in phagocytosis. I. Activity of some enzymes in phagocytic cells during infection with Streptococcus pyogenes in vivo.
    Tylewska S; Hryniewicz W
    Zentralbl Bakteriol Orig A; 1979 Oct; 245(1-2):33-43. PubMed ID: 44621
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effects of subinhibitory concentrations of antibiotics on the virulence of group A hemolytic Streptococci].
    Michel J; Ferne M; Rotenberg M
    Pathol Biol (Paris); 1983 Jun; 31(6):528-32. PubMed ID: 6348663
    [TBL] [Abstract][Full Text] [Related]  

  • 33. How to become a killer, or is it all accidental? Virulence strategies in oral streptococci.
    Sitkiewicz I
    Mol Oral Microbiol; 2018 Feb; 33(1):1-12. PubMed ID: 28727895
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Studies on the pathogenicity of Streptococcus pyogenes. II. Factors which influence the infectivity of group A haemolytic streptococcus in Swiss albino mice.
    COBURN AF; EVANS J; NATHAN J
    Br J Exp Pathol; 1954 Jun; 35(3):279-93. PubMed ID: 13172406
    [No Abstract]   [Full Text] [Related]  

  • 35. Studies on the pathogenicity of Streptococcus pyogenes. I. The experimental induction of respiratory tract infections in Swiss albino mice with group A haemolytic streptococcus.
    COBURN AF; EVANS J; NATHAN J
    Br J Exp Pathol; 1954 Jun; 35(3):270-8. PubMed ID: 13172405
    [No Abstract]   [Full Text] [Related]  

  • 36. Variation occurring in group A streptococci during human infection; progressive loss of M substance correlated with increasing susceptibility to bacteriostasis.
    ROTHBARD S; WATSON RF
    J Exp Med; 1948 Jun; 87(6):521-33. PubMed ID: 18858642
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Group A streptococcal M proteins: virulence factors and protective antigens.
    Robinson JH; Kehoe MA
    Immunol Today; 1992 Sep; 13(9):362-7. PubMed ID: 1281632
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fukugiside, a biflavonoid from Garcinia travancorica inhibits biofilm formation of Streptococcus pyogenes and its associated virulence factors.
    Nandu TG; Subramenium GA; Shiburaj S; Viszwapriya D; Iyer PM; Balamurugan K; Rameshkumar KB; Karutha Pandian S
    J Med Microbiol; 2018 Sep; 67(9):1391-1401. PubMed ID: 30052177
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phagocytic and bactericidal activity of human neutrophils against two isolates of Group B streptococci Type Ic of differing pathogenicity.
    Cleat PH; Coid CR
    Br J Exp Pathol; 1981 Aug; 62(4):393-7. PubMed ID: 7028073
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Streptococcus pyogenes CAMP factor attenuates phagocytic activity of RAW 264.7 cells.
    Kurosawa M; Oda M; Domon H; Saitoh I; Hayasaki H; Terao Y
    Microbes Infect; 2016 Feb; 18(2):118-27. PubMed ID: 26482504
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.